MoneyWorks4Me

Norris Medicines - Quaterly Results

25 May 2022 Evaluate
The sales for the March 2022 quarter moved down -68.18% to Rs. 8.19 millions as compared to Rs. 25.74 millions during the year ago period.The Net Loss for the quarter ended March 2022 is Rs. -22.33 millions as compared to Net Loss of Rs. -31.75 millions of corresponding quarter ended March 2021 Operating profit Margin for the quarter ended March 2022 improved to -4.15% as compared to -10.32% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 8.19 25.74 -68.18 94.38 122.51 -22.96 94.38 122.51 -22.96
Other Income 0.15 0.24 -37.50 0.26 0.50 -48.00 0.26 0.50 -48.00
PBIDT -4.15 -10.32 -59.79 -0.46 -16.91 -97.28 -0.46 -16.91 -97.28
Interest 0.82 10.47 -92.17 14.82 16.34 -9.30 14.82 16.34 -9.30
PBDT -4.97 -20.79 -76.09 -15.28 -33.25 -54.05 -15.28 -33.25 -54.05
Depreciation 6.57 1.27 417.32 6.57 6.67 -1.50 6.57 6.67 -1.50
PBT -11.54 -22.06 -47.69 -21.85 -39.92 -45.27 -21.85 -39.92 -45.27
TAX 10.79 9.69 11.35 10.79 9.69 11.35 10.79 9.69 11.35
Deferred Tax 10.79 9.69 11.35 10.79 9.69 11.35 10.79 9.69 11.35
PAT -22.33 -31.75 -29.67 -32.64 -49.61 -34.21 -32.64 -49.61 -34.21
Equity 99.26 99.26 0.00 99.26 99.26 0.00 99.26 99.26 0.00
PBIDTM(%) -50.67 -40.09 26.38 -0.49 -13.80 -96.47 -0.49 -13.80 -96.47
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..